Tuesday, September 22, 2026 | UTC
About | Contact | API Status
Sign In Subscribe
Live
AAPL $339.75 +0.23%
MSFT $498.00 -0.72%
GOOGL $351.16 -1.07%
AMZN $254.98 -1.34%
TSLA $378.90 +0.96%
META $736.60 -0.63%
NVDA $228.87 +0.66%
JPM $340.00 -3.42%
BTC $38.11 -0.37%
ETH $26.27 -0.34%
AAPL
$339.75
▲ 0.23%
MSFT
$498.00
▼ 0.72%
GOOGL
$351.16
▼ 1.07%
AMZN
$254.98
▼ 1.34%
TSLA
$378.90
▲ 0.96%
META
$736.60
▼ 0.63%
NVDA
$228.87
▲ 0.66%
JPM
$340.00
▼ 3.42%
All Markets Technology Economy Science Health Sports Entertainment Politics
Bloomberg Markets
Moderna, Merck Cancer Vax Gives Hope
Scientists are on the cusp of fulfilling a decades-long quest: to use vaccines to teach the immune system to spot and destroy cancer cells. News that an mRNA cancer vaccine developed by Merck & Co. and Moderna Inc. kept melanoma from returning in a large, late-stage trial marks a critical next chapter for a technology beleaguered by post-pandemic political backlash and years of false starts before then. Bloomberg Opinion Columnist Lisa Jarvis writes "Moderna and Merck's Cancer Vaccine Is a Marve
business  Aug 21, 2026

Stay ahead of the markets.

Get free access to breaking news, stock data, and market analysis.

Subscribe Free